Hudson Bay Capital Management’s NeoGenomics NEO Stock Holding History

Hudson Bay Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75,000	Closed	-$2.77M	–	665
2020 Q3	$2.77M	Hold	75,000	–	–	0.04%	312
2020 Q2	$2.32M	Buy	+75,000	New	+$2.08M	0.04%	297
2018 Q4	–	Sell	-25,000	Closed	-$384K	–	870
2018 Q3	$384K	Sell	25,000 -25,000	-50%	-$346K	﹤0.01%	635
2018 Q2	$656K	Sell	50,000 -77,500	-61%	-$853K	0.01%	676
2018 Q1	$1.04M	Sell	127,500 -22,500	-15%	-$182K	0.02%	567
2017 Q4	$1.33M	Sell	150,000 -15,000	-9%	-$138K	0.03%	367
2017 Q3	$1.84M	Sell	165,000 -30,000	-15%	-$292K	0.05%	253
2017 Q2	$1.75M	Sell	195,000 -5,000	-3%	-$39.7K	0.04%	353
2017 Q1	$1.58M	Buy	200,000 +50,000	+33%	+$407K	0.02%	531
2016 Q4	$1.29M	Buy	+150,000	New	+$1.28M	0.03%	438

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Hudson Bay Capital Management's NEO Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of NeoGenomics (NEO) in Q4 2020, closing a stake of 75,000 shares — an estimated $2.77M sold.

Hudson Bay Capital Management first reported a position in NEO in Q4 2016 and held it in 10 quarters. The position peaked at $2.77M in Q3 2020. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

Hudson Bay Capital Management reported no remaining NeoGenomics position as of Q4 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 75,000 NeoGenomics shares in Q4 2020, an estimated $2.77M.
Hudson Bay Capital Management first reported a position in NeoGenomics in Q4 2016 and held it in 10 quarters.
Hudson Bay Capital Management's NeoGenomics position peaked at $2.77M in Q3 2020.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.